标题
An overview of precision oncology basket and umbrella trials for clinicians
作者
关键词
-
出版物
CA-A CANCER JOURNAL FOR CLINICIANS
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2020-02-07
DOI
10.3322/caac.21600
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- FDA Approval Summary: Pembrolizumab for the treatment of microsatellite instability-high solid tumors
- (2019) Leigh Marcus et al. CLINICAL CANCER RESEARCH
- Finding driver mutations in cancer: Elucidating the role of background mutational processes
- (2019) Anna-Leigh Brown et al. PLoS Computational Biology
- RoB 2: a revised tool for assessing risk of bias in randomised trials
- (2019) Jonathan A C Sterne et al. BMJ-British Medical Journal
- Systematic review of basket trials, umbrella trials, and platform trials: a landscape analysis of master protocols
- (2019) Jay J. H Park et al. Trials
- Update on the types and usage of liquid biopsies in the clinical setting: a systematic review
- (2018) Borros Arneth BMC CANCER
- Clinical trials recruitment planning: A proposed framework from the Clinical Trials Transformation Initiative
- (2018) Grant D. Huang et al. Contemporary Clinical Trials
- Master protocols in lung cancer
- (2018) Vincent K. Lam et al. CURRENT OPINION IN ONCOLOGY
- Ado-Trastuzumab Emtansine for Patients With HER2-Mutant Lung Cancers: Results From a Phase II Basket Trial
- (2018) Bob T. Li et al. JOURNAL OF CLINICAL ONCOLOGY
- Basket trial of TRK inhibitors demonstrates efficacy in TRK fusion-positive cancers
- (2018) Yu Chen et al. Journal of Hematology & Oncology
- Precision oncology in the age of integrative genomics
- (2018) Chandan Kumar-Sinha et al. NATURE BIOTECHNOLOGY
- Canakinumab for the Treatment of Autoinflammatory Recurrent Fever Syndromes
- (2018) Fabrizio De Benedetti et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy of Larotrectinib in TRK Fusion–Positive Cancers in Adults and Children
- (2018) Alexander Drilon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vemurafenib for BRAF V600–Mutant Erdheim-Chester Disease and Langerhans Cell Histiocytosis
- (2018) Eli L. Diamond et al. JAMA Oncology
- A multi-histology basket trial of ado-trastuzumab emtansine in patients with HER2 amplified cancers.
- (2018) Bob T. Li et al. JOURNAL OF CLINICAL ONCOLOGY
- EA5142 adjuvant nivolumab in resected lung cancers (ANVIL).
- (2018) Jamie E. Chaft et al. JOURNAL OF CLINICAL ONCOLOGY
- Master Protocols to Study Multiple Therapies, Multiple Diseases, or Both
- (2017) Janet Woodcock et al. NEW ENGLAND JOURNAL OF MEDICINE
- Blockade of HLA Antibody-Triggered Classical Complement Activation in Sera From Subjects Dosed With the Anti-C1s Monoclonal Antibody TNT009—Results from a Randomized First-in-Human Phase 1 Trial
- (2017) Jakob Mühlbacher et al. TRANSPLANTATION
- Statistical controversies in clinical research: basket trials, umbrella trials, and other master protocols: a review and examples
- (2016) L. A. Renfro et al. ANNALS OF ONCOLOGY
- Is the NCI MATCH trial a match for gynecologic oncology?
- (2016) Kathleen N. Moore et al. GYNECOLOGIC ONCOLOGY
- Analytical Validation and Application of a Targeted Next-Generation Sequencing Mutation-Detection Assay for Use in Treatment Assignment in the NCI-MPACT Trial
- (2016) Chih-Jian Lih et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Towards precision medicine
- (2016) Euan A. Ashley NATURE REVIEWS GENETICS
- Core Concept: Basket trial approach capitalizes on the molecular mechanisms of tumors
- (2016) Stephen Ornes PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
- (2016) Jonathan AC Sterne et al. BMJ-British Medical Journal
- ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
- (2016) Jonathan AC Sterne et al. BMJ-British Medical Journal
- Tissue requirements in lung cancer diagnosis for tumor heterogeneity, mutational analysis and targeted therapies: initial experience with intra-operative Frozen Section Evaluation (FROSE) in bronchoscopic biopsies
- (2016) Jeffrey S. Iding et al. Journal of Thoracic Disease
- Driver and Passenger Mutations in Cancer
- (2015) Julia R. Pon et al. Annual Review of Pathology-Mechanisms of Disease
- ALCHEMIST Trials: A Golden Opportunity to Transform Outcomes in Early-Stage Non-Small Cell Lung Cancer
- (2015) R. Govindan et al. CLINICAL CANCER RESEARCH
- The Precision Medicine Initiative
- (2015) Euan A. Ashley JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial
- (2015) Christophe Le Tourneau et al. LANCET ONCOLOGY
- The Brave New World of clinical cancer research: Adaptive biomarker-driven trials integrating clinical practice with clinical research
- (2015) Donald A. Berry Molecular Oncology
- PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
- (2015) Dung T. Le et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations
- (2015) David M. Hyman et al. NEW ENGLAND JOURNAL OF MEDICINE
- A New Initiative on Precision Medicine
- (2015) Francis S. Collins et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Master Protocol Concept
- (2015) Mary W. Redman et al. SEMINARS IN ONCOLOGY
- FDA Approval Summary: Vemurafenib for Treatment of Unresectable or Metastatic Melanoma with the BRAFV600E Mutation
- (2014) G. Kim et al. CLINICAL CANCER RESEARCH
- FDA Approval: Ado-Trastuzumab Emtansine for the Treatment of Patients with HER2-Positive Metastatic Breast Cancer
- (2014) L. Amiri-Kordestani et al. CLINICAL CANCER RESEARCH
- Circulating Tumor DNA as a Liquid Biopsy for Cancer
- (2014) E. Heitzer et al. CLINICAL CHEMISTRY
- Precision Medicine Clinical Trials: Defining New Treatment Strategies
- (2014) Brandy M. Heckman-Stoddard et al. Seminars in Oncology Nursing
- ‘Master protocol’ aims to revamp cancer trials
- (2013) Heidi Ledford NATURE
- Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer
- (2012) Sunil Verma et al. NEW ENGLAND JOURNAL OF MEDICINE
- Designing phase II trials in cancer: a systematic review and guidance
- (2011) S R Brown et al. BRITISH JOURNAL OF CANCER
- Phase II study of fulvestrant in recurrent/metastatic endometrial carcinoma: A Gynecologic Oncology Group Study
- (2010) Allan L. Covens et al. GYNECOLOGIC ONCOLOGY
- Inhibition of Poly(ADP-Ribose) Polymerase in Tumors fromBRCAMutation Carriers
- (2009) Peter C. Fong et al. NEW ENGLAND JOURNAL OF MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started